These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6523177)

  • 1. Cardiac abnormalities in the thalassaemia syndromes.
    Yee H; Mra R; Nyunt KM
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):414-21. PubMed ID: 6523177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload.
    Leon MB; Borer JS; Bacharach SL; Green MV; Benz EJ; Griffith P; Nienhuis AW
    N Engl J Med; 1979 Nov; 301(21):1143-8. PubMed ID: 492276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemosiderosis in thalassemia major. Quantitative study with magnetic resonance (MR)].
    Rossi L; Castriota-Scanderbeg A; Ferrozzi F; Butturini A; Rossi A
    Radiol Med; 1992 Mar; 83(3):237-42. PubMed ID: 1579672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac study by dobutamine stress echocardiography in thalassemic patients.
    Mariotti E; Agostini A; Angelucci E; Cesaroni P; Lucarelli G; Sgarbi E
    Bone Marrow Transplant; 1993; 12 Suppl 1():14-5. PubMed ID: 8374553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
    Ong CK; Lim SL; Tan WC; Ong EE; Goh AS
    Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac complications in homozygous beta-thalassemia.
    Wonke B; Hoffbrand AV; Aldouri MA; Ward SE
    Prog Clin Biol Res; 1989; 309():51-6. PubMed ID: 2780750
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of the cardiovascular complications of thalassemia by echocardiography.
    Walker JM; Nair S
    Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac pathology in 47 patients with beta thalassaemia/haemoglobin E.
    Sonakul D; Pacharee P; Wasi P; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):554-63. PubMed ID: 6242076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac dysfunction in children with thalassemia major].
    Angelika L; Graf N; Hoffmann W
    Klin Padiatr; 1988; 200(2):102-7. PubMed ID: 3386182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiac manifestations of thalassemia major: natural history, noninvasive cardiac diagnostic studies and results of cardiac catheterization.
    Ehlers KH; Levin AR; Klein AA; Markenson AL; O'Loughlin JE; Engle MA
    Cardiovasc Clin; 1981; 11(2):171-86. PubMed ID: 7214380
    [No Abstract]   [Full Text] [Related]  

  • 12. MRI and iron-overload cardiomyopathy in thalassaemia.
    Pennell D
    Circulation; 2006 Mar; 113(11):f43-4. PubMed ID: 16552847
    [No Abstract]   [Full Text] [Related]  

  • 13. The heart in thalassemia: a comprehensive review.
    Sahasakul Y; Chithiraphan S
    J Med Assoc Thai; 1985 Oct; 68(10):517-27. PubMed ID: 3908610
    [No Abstract]   [Full Text] [Related]  

  • 14. Echocardiographic study in ex-thalassemic patients with iron overload, preliminary observations during phlebotomy therapy.
    Mariotti E; Agostini A; Angelucci E; Lucarelli G; Sgarbi E
    Bone Marrow Transplant; 1993; 12 Suppl 1():106-7. PubMed ID: 8374547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic abnormalities in thalassaemia major with multiple transfusions.
    Ee B; Tan SH; Yip WC; Tay JS; Chia BL; Wong HB
    J Singapore Paediatr Soc; 1981; 23(1-2):68-70. PubMed ID: 7343780
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
    Fung EB; Harmatz PR; Lee PD; Milet M; Bellevue R; Jeng MR; Kalinyak KA; Hudes M; Bhatia S; Vichinsky EP;
    Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cardiac function in patients with thalassemia major.
    Nienhuis AW; Griffith P; Strawczynski H; Henry W; Borer J; Leon M; Anderson WF
    Ann N Y Acad Sci; 1980; 344():384-96. PubMed ID: 6930878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.